VANGUARD GROUP INC - 28 Feb 2025 SCHEDULE 13G/A Report for Neurocrine Biosciences Inc Common Stock (NBIX)

Filing Manager
VANGUARD GROUP INC
Reporting Manager
The Vanguard Group
Symbol
NBIX
Shares outstanding
99,799,872 shares
Disclosed Ownership
10,129,687 shares
Ownership
10.2%
Form type
SCHEDULE 13G/A
Filing time
06 Mar 2025, 14:09:22 UTC
Date of event
28 Feb 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
The Vanguard Group 10.2% 10,129,687 0 66,089 Ashley Grim Head of Global Fund Administration